Market Tracker

04/21 5:16pm ET

Rosetta Genomics Ltd (NASDAQ:ROSG)

2.41
Delayed Data
As of Apr 21
 0.00 / 0.00%
Today’s Change
2.27
Today|||52-Week Range
18.60
-52.18%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close2.41
Today’s open2.38
Day’s range2.33 - 2.41
Volume23,827
Average volume (3 months)62,448
Market cap$5.7M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+10.85%
Earnings growth (this year)+55.65%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+523.06%
P/E ratio--
Price/Sales2.25
Price/Book0.21

Competitors

 Today’s
change
Today’s
% change
RGBPRegen BioPharma Inc+0.00+0.22%
ORPNBioblast Pharma Ltd+0.02+3.77%
XTNTXtant Medical Holdin...-0.02-3.56%
TENXTenax Therapeutics I...-0.00-0.86%
Data as of 4:02pm ET, 04/21/2017

Financials

Last reporting dateApril 3, 2017
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$8.3M
Annual profit (last year)-$17.3M
Net profit margin-209.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, Tel Aviv

Forecasts